CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection

BACKGROUND: Lack of adequate adjuvancy is a possible explanation for lack of vaccine immunogenecity. Immunostimulatory CpGs are potent vaccine adjuvants and may be an important component of the development vaccines, particularly those for which a cellular immune response is required for protection....

Descripción completa

Detalles Bibliográficos
Autores principales: Angel, Jonathan B, Cooper, Curtis L, Clinch, Jennifer, Young, Charlene D, Chenier, Andreane, Parato, Karl G, Lautru, Michael, Davis, Heather, Cameron, Donald W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526993/
https://www.ncbi.nlm.nih.gov/pubmed/18700037
http://dx.doi.org/10.1186/1476-8518-6-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526993/
https://www.ncbi.nlm.nih.gov/pubmed/18700037
http://dx.doi.org/10.1186/1476-8518-6-4

Ejemplares similares